Global Health Limited

Global Health Limited (MEDANTA) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.

Healthcare›Healthcare›Healthcare Services›Hospital

medanta.org(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-09-03

Stock price
₹1417.30
Market cap
38,065 Cr
Stock P/E
77.8
P/B
9.56
Dividend yield
0.0%

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales844 Cr833 Cr809 Cr861 Cr957 Cr943 Cr931 Cr1,031 Cr1,099 Cr1,121 Cr1,159 Cr1,304 Cr
Operating expenses (approx.)631 Cr621 Cr629 Cr675 Cr728 Cr706 Cr707 Cr804 Cr868 Cr904 Cr915 Cr1,017 Cr
EBITDA213 Cr212 Cr179 Cr186 Cr228 Cr238 Cr225 Cr227 Cr231 Cr217 Cr244 Cr287 Cr
OPM %25.2%25.5%22.2%21.6%23.9%25.2%24.1%22.0%21.0%19.4%21.0%22.0%
Other income21 Cr22 Cr27 Cr22 Cr18 Cr16 Cr23 Cr20 Cr20 Cr22 Cr37 Cr22 Cr
Interest20 Cr18 Cr18 Cr18 Cr16 Cr16 Cr15 Cr14 Cr17 Cr22 Cr27 Cr27 Cr
Depreciation43 Cr44 Cr45 Cr47 Cr49 Cr48 Cr49 Cr45 Cr50 Cr61 Cr67 Cr69 Cr
Profit before tax171 Cr172 Cr143 Cr144 Cr181 Cr189 Cr133 Cr208 Cr200 Cr120 Cr187 Cr213 Cr
Tax %26.6%28.3%11.0%26.0%27.8%24.4%24.0%23.6%20.7%20.7%24.4%26.3%
Net profit125 Cr124 Cr127 Cr106 Cr131 Cr143 Cr101 Cr159 Cr158 Cr95 Cr142 Cr157 Cr
EPS (₹)₹4.66₹4.61₹4.74₹3.96₹4.87₹5.32₹3.77₹5.92₹5.89₹3.54₹5.36₹5.91

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2023Mar 2024Mar 2025Mar 2026TTM
Sales2,694 Cr3,275 Cr3,692 Cr4,410 CrSign in for TTM
Operating expenses (approx.)2,082 Cr2,476 Cr2,815 Cr3,491 CrSign in for TTM
EBITDA612 Cr799 Cr877 Cr919 CrSign in for TTM
OPM %22.7%24.4%23.8%20.8%Sign in for TTM
Other income65 Cr75 Cr79 Cr99 CrSign in for TTM
Interest78 Cr74 Cr65 Cr79 CrSign in for TTM
Depreciation150 Cr173 Cr194 Cr223 CrSign in for TTM
Profit before tax449 Cr627 Cr647 Cr715 CrSign in for TTM
Tax %27.4%23.8%25.6%22.5%Sign in for TTM
Net profit326 Cr478 Cr481 Cr554 CrSign in for TTM
EPS (₹)₹12.58₹17.80₹17.92₹20.71Sign in for TTM
Dividend payout %0.0%0.0%0.0%2.4%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2023Mar 2024Mar 2025Mar 2026
Equity capital54 Cr54 Cr54 Cr54 Cr
Reserves2,375 Cr2,852 Cr3,333 Cr3,908 Cr
Borrowings842 Cr419 Cr328 Cr1,190 Cr
Other liabilities846 Cr979 Cr1,051 Cr731 Cr
Total liabilities4,116 Cr4,304 Cr4,766 Cr5,905 Cr
Fixed assets (net)1,708 Cr1,813 Cr1,975 Cr3,779 Cr
CWIP327 Cr386 Cr529 Cr132 Cr
Investments0.05 Cr0.05 Cr3 Cr3 Cr
Inventories60 Cr67 Cr67 Cr79 Cr
Trade receivables194 Cr215 Cr292 Cr411 Cr
Cash & bank767 Cr425 Cr230 Cr127 Cr
Other assets1,059 Cr1,398 Cr1,671 Cr1,374 Cr
Total assets4,116 Cr4,304 Cr4,766 Cr5,905 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity645 Cr612 Cr624 Cr714 Cr
Cash from investing-342 Cr-441 Cr-721 Cr-1,065 Cr
Cash from financing346 Cr-514 Cr-97 Cr248 Cr
Net cash flow648 Cr-343 Cr-194 Cr-103 Cr
Free cash flow (OCF − Capex)409 Cr334 Cr107 Cr-124 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2023Mar 2024Mar 2025Mar 2026
ROCE %16.1%21.1%19.2%15.3%
ROE %13.4%16.5%14.2%14.0%
Debtor days26242934
Inventory days38353133
Days payable1249990100
Cash conversion cycle-59-40-30-33
Debt / equity0.350.140.100.30
Current ratio2.762.442.482.67
Net debt / EBITDA0.12-0.00660.111.16

Compare with peers

Loading peers…